TOPDOX relaunched: from consumer to corporate
Portugal · Jul 18, 2017· By Bernice Tang
Half a million users later, productivity software startup TOPDOX made the jump to B2B. Its co-founder and CEO, Nelson Pereira, tells us why
When Nelson Pereira was creating a software where people could share and collaborate on documents regardless of their format, cloud or device, some answers seemed obvious enough.
It was 2014 and the world was smack bang in a smartphone explosion. Surely, Pereira thought, launching the software as a mobile app was the way to go, and winning users – millions of them – would be the best gauge of the product’s success.
Three years on, TOPDOX, the startup that Pereira co-founded, has turned its technology into a software as a service (SaaS) for corporate clients, who are in fact computer users. Many of these large enterprises haven’t yet moved their IT systems to the cloud, so TOPDOX is tweaking its technology to make sure it also runs on premise, on the companies’ physical servers. And instead of counting its users by millions, it is currently working with about 70 companies.
Sounds like a regression? Not at all. In fact, thanks to this business-model pivot, the startup is now looking to break even by the end of this year. Not bad for a company that relaunched its product in the B2B market only two months ago, and runs with a team of just five, namely the two co-founders, Pereira and Miguel Jesus, and three developers.
“The last two and a half years have been an amazing adventure of learning, with successes, with failures,” Pereira, who is also CEO of Porto-based TOPDOX, told CompassList.
“We got half a million registered users in just 10 months,” he said. “But we failed to scale, so we needed to build a more sustainable business model.
Edited by Bernice Tang
At CompassList, we pride ourselves on the accuracy of our information and reporting. Please help us by letting us know of any incomplete or inaccurate information on our website. Rest assured that we will handle every piece of feedback with care.